Bempegaldesleukin/Nivolumab and Challenges in First-line Treatment of Metastatic Urothelial Carcinoma

被引：7

作者：

Miron, Benjamin ^{[1
]}

Geynisman, Daniel M. ^{[1
]}

机构：

[1] Fox Chase Canc Ctr, Philadelphia, PA USA

来源：

EUROPEAN UROLOGY | 2022年 / 82卷 / 04期

关键词：

CHEMOTHERAPY; CISPLATIN; MULTICENTER;

D O I：

10.1016/j.eururo.2022.05.023

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：374 / 376

页数：3

共 13 条

[1]

[Anonymous], 2022, NEKTAR BRISTOL MYERS

[2] Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial [J].

Balar, Arjun V. ;

Galsky, Matthew D. ;

Rosenberg, Jonathan E. ;

Powles, Thomas ;

Petrylak, Daniel P. ;

Bellmunt, Joaquim ;

Loriot, Yohann ;

Necchi, Andrea ;

Hoffman-Censits, Jean ;

Perez-Gracia, Jose Luis ;

Dawson, Nancy A. ;

van der Heijden, Michiel S. ;

Dreicer, Robert ;

Srinivas, Sandy ;

Retz, Margitta M. ;

Joseph, Richard W. ;

Drakaki, Alexandra ;

Vaishampayan, Ulka N. ;

Sridhar, Srikala S. ;

Quinn, David I. ;

Duran, Ignacio ;

Shaffer, David R. ;

Eigl, Bernhard J. ;

Grivas, Petros D. ;

Yu, Evan Y. ;

Li, Shi ;

Kadel, Edward E., III ;

Boyd, Zachary ;

Bourgon, Richard ;

Hegde, Priti S. ;

Mariathasan, Sanjeev ;

Thastrom, AnnChristine ;

Abidoye, Oyewale O. ;

Fine, Gregg D. ;

Bajorin, Dean F. .

LANCET, 2017, 389 (10064) :67-76

[3]

Bristol Myers Squibb, BRIST MYERS SQUIBB P

[4] Randomized Phase II/III Trial Assessing Gemcitabine/Carboplatin and Methotrexate/Carboplatin/Vinblastine in Patients With Advanced Urothelial Cancer Who Are Unfit for Cisplatin-Based Chemotherapy: EORTC Study 30986 [J].

De Santis, Maria ;

Bellmunt, Joaquim ;

Mead, Graham ;

Kerst, J. Martijn ;

Leahy, Michael ;

Maroto, Pablo ;

Gil, Thierry ;

Marreaud, Sandrine ;

Daugaard, Gedske ;

Skoneczna, Iwona ;

Collette, Sandra ;

Lorent, Julie ;

de Wit, Ronald ;

Sylvester, Richard .

JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (02) :191-199

[5] Defining "platinum-ineligible" patients with metastatic urothelial cancer (mUC). [J].

Gupta, Shilpa ;

Sonpavde, Guru ;

Grivas, Petros ;

Apolo, Andrea B. ;

Plimack, Elizabeth R. ;

Flaig, Thomas W. ;

Hahn, Noah M. ;

Balar, Arjun Vasant ;

Bajorin, Dean F. ;

Galsky, Matt D. ;

Rosenberg, Jonathan E. .

JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)

[6]

National Institutes of Health National Cancer Institute, SURV EP END RES PROG

[7] First-line pembrolizumab (pembro) in cisplatin-ineligible patients with advanced urothelial cancer (UC): Response and survival results up to five years from the KEYNOTE-052 phase 2 study. [J].

O'Donnell, Peter H. ;

Balar, Arjun Vasant ;

Vuky, Jacqueline ;

Castellano, Daniel ;

Bellmunt, Joaquim ;

Powles, Thomas ;

Bajorin, Dean F. ;

Grivas, Petros ;

Hahn, Noah M. ;

Plimack, Elizabeth R. ;

Xu, Jin Zhi ;

Godwin, James Luke ;

Moreno, Blanca Homet ;

De Wit, Ronald .

JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)

[8] 1L pembrolizumab (pembro) versus chemotherapy (chemo) for choice-of-carboplatin patients with advanced urothelial carcinoma (UC) in KEYNOTE-361. [J].

Powles, Thomas ;

Csoszi, Tibor ;

Ozguroglu, Mustafa ;

Matsubara, Nobuaki ;

Geczi, Lajos ;

Cheng, Susanna Y. ;

Fradet, Yves ;

Oudard, Stephane ;

Vulsteke, Christof ;

Morales-Barrera, Rafael ;

Flechon, Aude ;

Gunduz, Seyda ;

Loriot, Yohann ;

Rodriguez-Vida, Alejo ;

Mamtani, Ronac ;

Yu, Evan Y. ;

Nam, Kijoeng ;

Imai, Kentaro ;

Moreno, Blanca Homet ;

Alva, Ajjai Shivaram .

JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)

[9] Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial [J].

Powles, Thomas ;

van der Heijden, Michiel S. ;

Castellano, Daniel ;

Galsky, Matthew D. ;

Loriot, Yohann ;

Petrylak, Daniel P. ;

Ogawa, Osamu ;

Park, Se Noon ;

Lee, Jae-Lyun ;

De Giorgi, Ugo ;

Bogemann, Martin ;

Bamias, Aristotelis ;

Eigl, Bernhard J. ;

Gurney, Howard ;

Mukherjee, Som D. ;

Fradet, Yves ;

Skoneczna, Iwona ;

Tsiatas, Marinos ;

Novikov, Andrey ;

Suarez, Cristina ;

Fay, Andre P. ;

Duran, Ignacio ;

Necchi, Andrea ;

Wildsmith, Sophie ;

He, Philip ;

Angra, Natasha ;

Gupta, Ashok K. ;

Levin, Wendy ;

Bellmunt, Joaquim .

LANCET ONCOLOGY, 2020, 21 (12) :1574-1588

[10] Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma [J].

Powles, Thomas ;

Park, Se Hoon ;

Voog, Eric ;

Caserta, Claudia ;

Valderrama, Begona P. ;

Gurney, Howard ;

Kalofonos, Haralabos ;

Radulovic, Sinisa ;

Demey, Wim ;

Ullen, Anders ;

Loriot, Yohann ;

Sridhar, Srikala S. ;

Tsuchiya, Norihiko ;

Kopyltsov, Evgeny ;

Sternberg, Cora N. ;

Bellmunt, Joaquim ;

Aragon-Ching, Jeanny B. ;

Petrylak, Daniel P. ;

Laliberte, Robert ;

Wang, Jing ;

Huang, Bo ;

Davis, Craig ;

Fowst, Camilla ;

Costa, Nuno ;

Blake-Haskins, John A. ;

di Pietro, Alessandra ;

Grivas, Petros .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (13) :1218-1230

← 1 2 →